The European Society of Cardiology released today new Guidelines for the Management of Stable Angina Pectoris. The updated Guidelines include information on new developments in cardiovascular care, advances that have been made in improving the prognosis of coronary artery disease including the use of statins and ACE inhibitors, as well as strategies to alleviate symptoms.
The Guidelines also provide updated information in the area of risk stratification and define which patients should
One of the world’s leading flu experts, Alan Hampson, a member of the World Health Organization (WHO) Pandemic Influenza Taskforce and advisor to the Australian Government, is to edit the first international journal dedicated to the subject.
He has been appointed Editor of Influenza and Other Respiratory Viruses, which is being launched by Blackwell Publishing amid growing international concerns about the possibility of an influenza pandemic.
“Alan Hampson is an ideal choic
A potentially ground-breaking treatment for nerve damage caused by diabetes has shown promising results in preclinical and early patient trials.
The University of Manchester team has discovered that injection of a novel therapeutic that works by stimulating a person’s genes may prevent nerve damage – primarily to the hands and feet – caused by the disease.
The positive preclinical results – reported in the journal Diabetes – are further evidence that the research cou
Aided by a powerful imaging technique, scientists have discovered they can detect smoking-related lung damage in healthy smokers who otherwise display none of the telltale signs of tobacco use.
Researchers at the University of Wisconsin-Madison were able to probe deeper into smokers’ lungs by tracking the movement in the respiratory organs of a harmless gas known as helium. Helium can be inhaled and visually detected via the widely used diagnostic technique known as magnet
Little-known disorder may affect as much as 2 percent of the population, studies suggest
Researchers at Harvard University and University College London have developed diagnostic tests for prosopagnosia, a socially disabling inability to recognize or distinguish faces. They’ve already used the new test and a related web site (www.faceblind.org) to identify hundreds of “face-blind” individuals, far more than scientists had identified previously.
The researchers, led
Patients with Irritable Bowel Syndrome (IBS) who took part in hypnotherapy sessions reported reduced symptoms and improved quality of life, according to research published in the June issue of Journal of Clinical Nursing.
Dr Graeme D Smith from University of Edinburgh studied 75 patients with IBS – which affects up to one in seven adults – before and after they took part in four to five treatment sessions over three months.
He discovered that before the sessions, women wer
In most developed countries safe blood transfusion is taken for granted. But blood grouping is a complex business, and not all blood groups are compatible. In order to check for compatibility, two cross-matching tests are carried out prior to transfusion – but these tests are based on technology that has not changed since the early days of blood transfusions.
Now a consortium called Bloodgen, led by the University of the West of England (UWE), Bristol, is nearing the end of a three-ye
Methylphenidate (Ritalin) elevates norepinephrine levels in the brains of rats to help focus attention while suppressing nerve signal transmissions in the sensory pathways to make it easier to block out extraneous stimuli, a Philadelphia research team has found.
Their report in the Journal of Neurophysiology helps explain how a stimulant aids people with attention deficit and hyperactivity disorders to improve their focus without increasing their motor activity. Methylphenidate, prescr
The severe neurodegeneration associated with HuntingtonÕs disease may result from molecular mutations that block the transport of nutrients within cells. Findings from the Emory University School of Medicine indicate that the mutant huntingtin protein limits the efforts of the huntingtin-associated protein-1 (HAP1) to provide nutrients to growing neurons, or neurites. Without those nutrients, neurites fail to develop and mature neurons degenerate.
Huntington’s disease was first
Eating fatty food does not appear to increase the risk of skin cancer. A study published today in the open access international journal BMC Cancer contradicts previous research that showed a link between high fat intake and certain types of skin cancer. The results of this latest study suggest that high fat intake might even play a protective role in the development of non-melanoma skin cancer.
Robert Granger and colleagues from the Menzies Research Institute in Hobart, Australia and col
Uterine fibroids affect the health and quality of life of more than six million women in the US every year
Researchers at the University of Pennsylvania School of Medicine are working on ways to improve the results of a non-surgical method to treat fibroids. They are examining the overall effectiveness of different agents used to destroy uterine fibroids – a discovery that could lead to more answers about the durability of a procedure called Uterine Fibroid Embolization (UFE). I
A Penn State College of Medicine pilot study suggests that a drug used to ease symptoms of alcohol and drug addiction may also bring relief to people with Crohn’s disease, a chronic inflammatory disorder of the intestine that affects an estimated 500,000 Americans.
In the study, patients with diagnosed Crohn’s disease were treated with a low dose of naltrexone, an FDA-approved drug used to ease symptoms of withdrawal from substance abuse, and monitored for improvement o
Researchers funded by the Canadian Institutes of Health Research (CIHR) and the Canadian Diabetes Association (CDA) have identified an unsuspected role of a protein named SHP-1 that could constitute a new therapeutic path against Type 2 Diabetes.
Under the direction of professor André Marette (Laval University), Nicole Beauchemin (McGill University), Martin Oliver (McGill University Health Centre) and Katherine Siminovitch (University of Toronto) were part of a Canadian and Am
A major fundraising campaign to extend facilities and clinical research programmes for diabetes in Perth and Kinross receives its local launch at Perth Council Chambers on Tuesday May 30th.
Provost Bob Scott will host the reception for the Perth “People’s Launch” of the Diabetes Research Campaign, which has been launched by the University of Dundee and aims to raise £3 million across Tayside.
A key part of the campaign is to provide state-of-the-art clinical research f
Two wildly different pathogens – one that infects vegetables, the other infecting humans – essentially use the same protein code to get their disease-causing proteins into the cells of their respective hosts.
That’s what researchers from Ohio State and Northwestern universities report in a study published in the current issue of the journal PLoS Pathogens. The scientists were surprised to learn that the pathogen that causes malaria in humans and the microbe that caused the Ir
A new technology to enable pharmaceutical companies to determine more effectively, and earlier on in clinical trials, whether an experimental drug is toxic to the heart has taken an important step toward the marketplace.
The University of Rochester Medical Center (URMC) and iCardiac Technologies, Inc. have signed an exclusive agreement to commercialize software developed by biomedical engineer Jean-Philippe Couderc, Ph.D., that provides a more accurate and reliable method to an
Feedback
